Suivre
Joanna Obacz
Titre
Citée par
Citée par
Année
Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy
SE Logue, EP McGrath, P Cleary, S Greene, K Mnich, A Almanza, ...
Nature communications 9 (1), 3267, 2018
2282018
Dual IRE 1 RN ase functions dictate glioblastoma development
S Lhomond, T Avril, N Dejeans, K Voutetakis, D Doultsinos, M McMahon, ...
EMBO molecular medicine 10 (3), e7929, 2018
1522018
Endoplasmic reticulum proteostasis in glioblastoma—From molecular mechanisms to therapeutic perspectives
J Obacz, T Avril, PJ Le Reste, H Urra, V Quillien, C Hetz, E Chevet
Science signaling 10 (470), eaal2323, 2017
1282017
Cross-talk between HIF and p53 as mediators of molecular responses to physiological and genotoxic stresses
J Obacz, S Pastorekova, B Vojtesek, R Hrstka
Molecular cancer 12 (1), 1-10, 2013
1042013
CD90 expression controls migration and predicts dasatinib response in glioblastoma
T Avril, A Etcheverry, R Pineau, J Obacz, G Jegou, F Jouan, PJ Le Reste, ...
Clinical Cancer Research 23 (23), 7360-7374, 2017
632017
Control of anterior GR adient 2 (AGR 2) dimerization links endoplasmic reticulum proteostasis to inflammation
M Maurel, J Obacz, T Avril, YP Ding, O Papadodima, X Treton, F Daniel, ...
EMBO molecular medicine 11 (6), e10120, 2019
582019
The role of AGR2 and AGR3 in cancer: similar but not identical
J Obacz, M Takacova, V Brychtova, P Dobes, S Pastorekova, B Vojtesek, ...
European journal of cell biology 94 (3-4), 139-147, 2015
502015
Regulation of tumor–stroma interactions by the unfolded protein response
J Obacz, T Avril, C Rubio‐Patiño, JP Bossowski, A Igbaria, JE Ricci, ...
The FEBS Journal 286 (2), 279-296, 2019
412019
Anterior gradient protein 3 is associated with less aggressive tumors and better outcome of breast cancer patients
J Obacz, V Brychtova, J Podhorec, P Fabian, P Dobes, B Vojtesek, ...
OncoTargets and therapy, 1523-1532, 2015
252015
Tamoxifen-Dependent Induction of AGR2 Is Associated with Increased Aggressiveness of Endometrial Cancer Cells
R Hrstka, J Podhorec, R Nenutil, L Sommerová, J Obacz, M Durech, ...
Cancer Investigation 35 (5), 313-324, 2017
232017
Biological basis for novel mesothelioma therapies
J Obacz, H Yung, M Shamseddin, E Linnane, X Liu, AA Azad, DM Rassl, ...
British Journal of Cancer 125 (8), 1039-1055, 2021
212021
Use of preclinical models for malignant pleural mesothelioma
M Shamseddin, J Obacz, MJ Garnett, RC Rintoul, HE Francies, ...
Thorax 76 (11), 1154-1162, 2021
192021
Extracellular AGR3 regulates breast cancer cells migration via Src signaling
J Obacz, L Sommerova, D Sicari, M Durech, T Avril, F Iuliano, ...
Oncology letters 18 (5), 4449-4456, 2019
192019
Inhibition of METTL3 results in a cell-intrinsic interferon response that enhances antitumor immunity
AA Guirguis, Y Ofir-Rosenfeld, K Knezevic, W Blackaby, D Hardick, ...
Cancer Discovery 13 (10), 2228-2247, 2023
132023
Novel IRE1-dependent proinflammatory signaling controls tumor infiltration by myeloid cells
J Obacz, J Archambeau, D Sicari, PJ Le Reste, R Pineau, S Martin, ...
42019
Dual IRE1 RNase functions dictate glioblastoma development
S Lhomond, T Avril, N Dejeans, K Voutetakis, D Doultsinos, M McMahon, ...
EMBO Molecular Medicine 14 (2), e15622, 2022
32022
Constitutive UPRER activation sustains tumor cell differentiation
D Doultsinos, M McMahon, K Voutetakis, J Obacz, R Pineau, P Le Reste, ...
32019
IRE1 endoribonuclease signaling promotes myeloid cell infiltration in glioblastoma
J Obacz, J Archambeau, E Lafont, M Nivet, S Martin, M Aubry, ...
Neuro-oncology, noad256, 2023
22023
IRE1-UBE2D3 signaling controls the recruitment of myeloid cells to glioblastoma
J Obacz, J Archambeau, PJ Le Reste, R Pineau, F Jouan, K Barroso, ...
bioRxiv, 533018, 2019
22019
Single-cell transcriptomic analysis of human pleura reveals stromal heterogeneity and informs in vitro models of mesothelioma
J Obacz, JA Valer, R Nibhani, TS Adams, JC Schupp, N Veale, ...
European Respiratory Journal 63 (1), 2024
12024
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20